GTS Securities’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-28,817
Closed -$111K 1222
2024
Q3
$111K Buy
+28,817
New +$111K ﹤0.01% 1566
2024
Q2
Sell
-50,110
Closed -$129K 1546
2024
Q1
$129K Buy
50,110
+18,670
+59% +$48.2K ﹤0.01% 1249
2023
Q4
$78.6K Buy
+31,440
New +$78.6K ﹤0.01% 1399
2023
Q3
Hold
0
1377